Extended clinical study of DSP-1958
Phase of Trial: Phase I
Latest Information Update: 16 Apr 2018
At a glance
- Drugs Thiotepa (Primary)
- Indications Brain cancer; Lymphoma; Solid tumours
- Focus Adverse reactions
- Sponsors Sumitomo Dainippon Pharma
- 09 Apr 2018 Planned number of patients changed from 30 to 50.
- 12 Sep 2017 Status changed from not yet recruiting to recruiting.
- 28 Jul 2017 New trial record